APOE and diabetes mellitus: Very recently, Junyan Lu et al. found that systemic administration of irisin ameliorated atherosclerosis induced by diabetes in Apo E-deficient mice by suppressing high glucose-induced endothelial dysfunction and apoptosis [28].